PanGenex has seen a recent decline in share price with little volume, indicating in my opinion limited to no dilution in the marketplace. Recent press shows them presenting their products with good reception and specific interest in carrying their product line nationwide.
PanGenex is a publicly traded corporation and pursues business opportunities in the $70 billion dollar nutraceutical and dietary supplement industry. With a focus specifically on the cardiovascular health segment, PanGenex develops and markets sector leading, patented or patent pending, condition specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Each product is scientifically formulated to address specific health conditions throughout the population. Many of our products contain the purest grade of nutraceutical components available anywhere without a prescription. PanGenex markets products through healthcare practitioners throughout the U.S., fine retail establishments and the internet on websites such as www.HeartHealthyWorld.com and www.Calgenex.com .
$0.06 (08/28/08)
